Is SHPHF or ORCC a better dividend investment in 2026?

SHPHF currently yields 1.45% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: ORCC offers higher current income.

What is the dividend yield difference between SHPHF and ORCC?

SHPHF has a forward dividend yield of 1.45% ($0.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 8.34 percentage points.

Home › Compare › SHPHF vs ORCC

SHPHF vs ORCC: Dividend Comparison 2026

SHPHF yields 1.45% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SHPHF wins by $2.4K in total portfolio value· pulled ahead in Year 5

INVESTMENT

TIME HORIZON10 years

SHPHF

● Live price

1.45%

Share price

$0.19

Annual div

$0.00

5Y div CAGR

12.4%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$23.8K

Annual income

$550.34

Full SHPHF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — SHPHF vs ORCC

📍 SHPHF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SHPHF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SHPHF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SHPHF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHPHF

Annual income on $10K today (after 15% tax)

$123.06/yr

After 10yr DRIP, annual income (after tax)

$467.79/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, SHPHF beats the other by $466.91/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHPHF + ORCC for your $10,000?

SHPHF: 50%ORCC: 50%

100% ORCC50/50100% SHPHF

Portfolio after 10yr

$22.6K

Annual income

$275.69/yr

Blended yield

1.22%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

SHPHF

No analyst data

Altman Z

1.9

Piotroski

5/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHPHF buys

ORCC buys

No recent congressional trades found for SHPHF or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSHPHFORCC

Forward yield	1.45%	9.79% ✓
Annual dividend / share	$0.00	$1.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	12.4% ✓	-50%
Portfolio after 10y	$23.8K ✓	$21.4K
Annual income after 10y	$550.34 ✓	$1.04
Total dividends collected	$3.2K ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: SHPHF vs ORCC ($10,000, DRIP)

Year	SHPHF Portfolio	SHPHF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1	$10,863	$162.72	$11,190	$489.61	$327.00 → ORCC
2	$11,809	$185.68	$12,229	$256.01	$420.00 → ORCC
3	$12,847	$212.04	$13,216	$130.74	$369.00 → ORCC
4	$13,989	$242.33	$14,207	$66.02	$218.00 → ORCC
5← crossover	$15,246	$277.19	$15,234	$33.17	+$12.00 → SHPHF
6	$16,630	$317.33	$16,317	$16.62	+$313.00 → SHPHF
7	$18,158	$363.61	$17,468	$8.32	+$690.00 → SHPHF
8	$19,846	$417.05	$18,695	$4.16	+$1.2K → SHPHF
9	$21,714	$478.83	$20,006	$2.08	+$1.7K → SHPHF
10	$23,784	$550.34	$21,407	$1.04	+$2.4K → SHPHF

SHPHF vs ORCC: Complete Analysis 2026

SHPHF — Stock

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

Full SHPHF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this SHPHF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHPHF vs SCHD SHPHF vs JEPI SHPHF vs O SHPHF vs KO SHPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.